Skip to main content
Top
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Metastasis | Research

Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineation

Authors: Yujie Wang, Weixiang Qi, Haoping Xu, Miao Zhang, Yimin Han, Jiayi Chen, Cheng Xu

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

Background

Despite increasing clinical data suggest that internal mammary node (IMN) irradiation would improve local-regional control and overall survival in breast cancer, its role remains controversial due to increased risk of cardiac and pulmonary toxicity. The current study aims to determine the high risk areas of IMN metastases by collecting and analyzing the axial imaging of IMN involvement, in order to optimize IMN delineation for breast cancer.

Methods

Breast cancer patients with IMN involvement were retrospectively identified from single-center database. All available imaging modalities including thoracic CT, breast MRI, ultrasound and PET/CT were used to diagnose IMN metastases. Anatomical characteristics from axial imaging, including distribution of involved ribs and distance from the internal mammary vessels (IMV), were collected for each metastatic IMN. What’s more,the natural infiltration tendency of IMNs from IMV was calculated in this study.

Results

In total, 83 metastatic IMNs from 70 breast cancer patients (initial diagnosed:34 and recurrence: 36) were located from axial CT image in this study. The second intercostal space was the most likely involved in patients with single(n = 35, 53.0%) and multiple intercostal space (n = 31, 47.0%) involvement. The percentage of including IMN with a 5 mm, 6 mm and 7 mm medial/lateral distance to the IMV were 75.9% (63/83), 89.2.6% (74/83) and 92.3% (77/83) respectively. While in maximal dorsal/ventral distance, nearly 95% of the nodes were encompassed into 6 mm depth to the IMV. Over 65% of IMN adenopathy (32/49,65.3%) were found to have a growth direction close to the sternum. By retrospective reviewing diagnostic reports, MRI demonstrated a high diagnostic performance in diagnosis of IMN disease (90.3%, 28/31), while CT had a higher misdiagnosis rate (22/63, 34.9%). The diagnostic efficiency of IMN could be improved if different methods were combined.

Conclusions

For patients with indications of prophylactic IMN irradiation, a 7 mm medial and 6 mm dorsal distance to the IMV on axial CT would be optimal to cover the clinical volume of IMN; and it would be reasonable to extend clinical tumor volume (CTV) coverage towards sternum for patients with evident IMN disease. Multi-imaging modalities are recommended to improve the diagnostic specificity and sensitivity of IMN metastases.
Literature
2.
go back to reference van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234(1):79–84.PubMedPubMedCentralCrossRef van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234(1):79–84.PubMedPubMedCentralCrossRef
3.
go back to reference Byrd DR, Dunnwald LK, Mankoff DA, Anderson BO, Moe RE, Yeung RS, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol. 2001;8(3):234–40.PubMedCrossRef Byrd DR, Dunnwald LK, Mankoff DA, Anderson BO, Moe RE, Yeung RS, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol. 2001;8(3):234–40.PubMedCrossRef
4.
go back to reference Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nuc Med. 1995;36(10):1775–80. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, et al. Mammary lymphoscintigraphy in breast cancer. J Nuc Med. 1995;36(10):1775–80.
6.
go back to reference Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008;107(3):379–87.PubMedCrossRef Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, et al. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008;107(3):379–87.PubMedCrossRef
7.
go back to reference Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198(6):681–4.PubMedPubMedCentralCrossRef Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198(6):681–4.PubMedPubMedCentralCrossRef
8.
go back to reference Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2(1):32–7.PubMedCrossRef Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2(1):32–7.PubMedCrossRef
9.
go back to reference Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977;39(2):533–8.PubMedCrossRef Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977;39(2):533–8.PubMedCrossRef
10.
go back to reference DeSelm C, Yang TJ, Cahlon O, Tisnado J, Khan A, Gillespie E, et al. A 3-dimensional mapping analysis of regional nodal recurrences in breast Cancer. Int J Radiat Oncol Biol Phys. 2019;103(3):583–91.PubMedCrossRef DeSelm C, Yang TJ, Cahlon O, Tisnado J, Khan A, Gillespie E, et al. A 3-dimensional mapping analysis of regional nodal recurrences in breast Cancer. Int J Radiat Oncol Biol Phys. 2019;103(3):583–91.PubMedCrossRef
11.
go back to reference Cranenbroek S, van der Sangen MJ, Kuijt GP, Voogd AC. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat. 2005;89(3):271–5.PubMed Cranenbroek S, van der Sangen MJ, Kuijt GP, Voogd AC. Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat. 2005;89(3):271–5.PubMed
12.
go back to reference Arriagada R, Le MG, Mouriesse H, Fontaine F, Dewar J, Rochard F, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. 1988;11(3):213–22.PubMedCrossRef Arriagada R, Le MG, Mouriesse H, Fontaine F, Dewar J, Rochard F, et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol. 1988;11(3):213–22.PubMedCrossRef
13.
go back to reference Poortmans P, Collette S, Struikmans H, Winter KD, Limbergen EV, Kirkove C, et al. Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. J Clin Oncol. 2018;36(15_suppl):504.CrossRef Poortmans P, Collette S, Struikmans H, Winter KD, Limbergen EV, Kirkove C, et al. Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. J Clin Oncol. 2018;36(15_suppl):504.CrossRef
14.
go back to reference McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, England). 2014;383(9935):2127–35.CrossRef McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, England). 2014;383(9935):2127–35.CrossRef
15.
go back to reference Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast Cancer. N Engl J Med. 2015;373(4):307–16.PubMedPubMedCentralCrossRef Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast Cancer. N Engl J Med. 2015;373(4):307–16.PubMedPubMedCentralCrossRef
16.
go back to reference Thorsen LB, Offersen BV, Dano H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast Cancer. J Clin Oncol. 2016;34(4):314–20.PubMedCrossRef Thorsen LB, Offersen BV, Dano H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast Cancer. J Clin Oncol. 2016;34(4):314–20.PubMedCrossRef
17.
go back to reference Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.PubMedCrossRef Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.PubMedCrossRef
18.
go back to reference Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast Cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.PubMedPubMedCentralCrossRef Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, et al. Estimating the risks of breast Cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–9.PubMedPubMedCentralCrossRef
19.
go back to reference Cao L, Cai G, Chang C, Miao AY, Yu XL, Yang ZZ, et al. Diastolic dysfunction occurs early in HER2-positive breast Cancer patients treated concurrently with radiation therapy and Trastuzumab. Oncologist. 2015;20(6):605–14.PubMedPubMedCentralCrossRef Cao L, Cai G, Chang C, Miao AY, Yu XL, Yang ZZ, et al. Diastolic dysfunction occurs early in HER2-positive breast Cancer patients treated concurrently with radiation therapy and Trastuzumab. Oncologist. 2015;20(6):605–14.PubMedPubMedCentralCrossRef
20.
go back to reference Cao L, Hu WG, Kirova YM, Yang ZZ, Cai G, Yu XL, et al. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy. Cancer Radiother. 2014;18(2):119–24.PubMedCrossRef Cao L, Hu WG, Kirova YM, Yang ZZ, Cai G, Yu XL, et al. Potential impact of cardiac dose-volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy. Cancer Radiother. 2014;18(2):119–24.PubMedCrossRef
21.
go back to reference de Graaf H, Dolsma WV, Willemse PH, van der Graaf WT, Sleijfer DT, de Vries EG, et al. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer. Br J Cancer. 1997;76(7):943–5.PubMedPubMedCentralCrossRef de Graaf H, Dolsma WV, Willemse PH, van der Graaf WT, Sleijfer DT, de Vries EG, et al. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer. Br J Cancer. 1997;76(7):943–5.PubMedPubMedCentralCrossRef
22.
go back to reference Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49(4):1023–8.PubMedCrossRef Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys. 2001;49(4):1023–8.PubMedCrossRef
23.
go back to reference Verhoeven K, Weltens C, Remouchamps V, Mahjoubi K, Veldeman L, Lengele B, et al. Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy - PROCAB guidelines. Radio Oncol. 2016;118(1):209–10.CrossRef Verhoeven K, Weltens C, Remouchamps V, Mahjoubi K, Veldeman L, Lengele B, et al. Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy - PROCAB guidelines. Radio Oncol. 2016;118(1):209–10.CrossRef
24.
go back to reference Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016;118(1):205–8.PubMedCrossRef Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016;118(1):205–8.PubMedCrossRef
25.
go back to reference Olivotto IA, Whelan TJ, Parpia S, Kim DH, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31(32):4038–45.PubMedCrossRef Olivotto IA, Whelan TJ, Parpia S, Kim DH, Berrang T, Truong PT, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31(32):4038–45.PubMedCrossRef
26.
go back to reference Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta oncologica (Stockholm, Sweden). 2013;52(4):703–10.CrossRef Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta oncologica (Stockholm, Sweden). 2013;52(4):703–10.CrossRef
27.
go back to reference Cheon H, Kim HJ, Lee SW, Kim DH, Lee CH, Cho SH, et al. Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors. Breast Cancer Res Treat. 2016;160(3):523–30.PubMedCrossRef Cheon H, Kim HJ, Lee SW, Kim DH, Lee CH, Cho SH, et al. Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors. Breast Cancer Res Treat. 2016;160(3):523–30.PubMedCrossRef
28.
go back to reference Noushi F, Spillane AJ, Uren RF, Gebski V. Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence. Breast (Edinburgh, Scotland). 2011;20(3):278–83.CrossRef Noushi F, Spillane AJ, Uren RF, Gebski V. Internal mammary lymph node metastasis in breast cancer: predictive models to assist with prognostic influence. Breast (Edinburgh, Scotland). 2011;20(3):278–83.CrossRef
29.
go back to reference Kinoshita T, Odagiri K, Andoh K, Doiuchi T, Sugimura K, Shiotani S, et al. Evaluation of small internal mammary lymph node metastases in breast cancer by MRI. Radiat Med. 1999;17(3):189–93.PubMed Kinoshita T, Odagiri K, Andoh K, Doiuchi T, Sugimura K, Shiotani S, et al. Evaluation of small internal mammary lymph node metastases in breast cancer by MRI. Radiat Med. 1999;17(3):189–93.PubMed
30.
go back to reference Savaridas SL, Spratt JD, Cox J. Incidence and potential significance of internal mammary lymphadenopathy on computed tomography in patients with a diagnosis of primary breast Cancer. Breast Cancer (Auckl). 2015;9:59–65. Savaridas SL, Spratt JD, Cox J. Incidence and potential significance of internal mammary lymphadenopathy on computed tomography in patients with a diagnosis of primary breast Cancer. Breast Cancer (Auckl). 2015;9:59–65.
31.
go back to reference Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys. 2010;77(4):1113–9.PubMedCrossRef Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys. 2010;77(4):1113–9.PubMedCrossRef
32.
go back to reference Heuts EM, van der Ent FW, Hulsewe KW, von Meyenfeldt MF, Voogd AC. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast (Edinburgh, Scotland). 2009;18(4):254–8.CrossRef Heuts EM, van der Ent FW, Hulsewe KW, von Meyenfeldt MF, Voogd AC. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast (Edinburgh, Scotland). 2009;18(4):254–8.CrossRef
33.
go back to reference Veronesi U, Arnone P, Veronesi P, Galimberti V, Luini A, Rotmensz N, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19(9):1553–60.PubMedCrossRef Veronesi U, Arnone P, Veronesi P, Galimberti V, Luini A, Rotmensz N, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19(9):1553–60.PubMedCrossRef
34.
go back to reference Yu J, Li G, Li J, Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005;61(3):874–8.PubMedCrossRef Yu J, Li G, Li J, Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys. 2005;61(3):874–8.PubMedCrossRef
35.
go back to reference Jethwa KR, Kahila MM, Hunt KN, Brown LC, Corbin KS, Park SS, et al. Delineation of internal mammary nodal target volumes in breast Cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):762–9.PubMedCrossRef Jethwa KR, Kahila MM, Hunt KN, Brown LC, Corbin KS, Park SS, et al. Delineation of internal mammary nodal target volumes in breast Cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):762–9.PubMedCrossRef
36.
go back to reference Urano M, Denewar FA, Murai T, Mizutani M, Kitase M, Ohashi K, et al. Internal mammary lymph node metastases in breast cancer: what should radiologists know? Jpn J Radiol. 2018;36(11):629–40.PubMedCrossRef Urano M, Denewar FA, Murai T, Mizutani M, Kitase M, Ohashi K, et al. Internal mammary lymph node metastases in breast cancer: what should radiologists know? Jpn J Radiol. 2018;36(11):629–40.PubMedCrossRef
Metadata
Title
Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineation
Authors
Yujie Wang
Weixiang Qi
Haoping Xu
Miao Zhang
Yimin Han
Jiayi Chen
Cheng Xu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1412-z

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue